美股详情

本页面由Tiger Trade Technology Pte. Ltd.提供服务

Parabilis Medicines

38.43

-0.9300-2.36%

盘后：38.430.00000.00%16:10 EDT

成交量：34.03万

成交额：1,315.87万

市值：47.65亿

市盈率：-1.64

高：40.56

开：39.42

低：38.00

收：39.36

52周最高：41.49

52周最低：24.51

股本：1.24亿

流通股本：3,350.00万

量比：0.85

换手率：1.02%

股息：- -

股息率：- -

每股收益(TTM):-23.4458

每股收益(LYR):-60.0402

净资产收益率：--

总资产收益率：--

市净率：4.55

市盈率(LYR):-0.64

数据加载中...

总览公司新闻资讯公告

公司资料

公司名字：

Parabilis Medicines

交易所：

NASDAQ

成立时间：

2015

员工人数：

145

公司地址：

30 Acorn Park Drive,Cambridge,Massachusetts,United States

官网：

http://www.parabilismed.com

邮编：

02140

电话：

传真：

- -

简介：

Parabilis Medicines, Inc.于2015年7月10日在特拉华州注册成立。该公司是一家临床阶段的生物制药公司，旨在开发变革性药物，解决历史上驱动人类疾病的不可药物蛋白靶点。其专有平台开创了Helicons，稳定的螺旋肽被设计用于细胞渗透，能够以高特异性结合扁平的细胞内蛋白质目标表面。

董事

名称

职位

Mathai Mammen

Chairman and Chief Executive Officer and Director and President

Alan M. Sebulsky

Director

Alexis Borisy

Director

Barbara Weber

Director

Edward Fitzgerald

Director

Jake Simson

Director

Krishna Yeshwant

Director

Rick Klausner

Director

股东

名称

职位

Mathai Mammen

Chairman and Chief Executive Officer and Director and President

Thomas Kotarakos

Chief Financial Officer

Fawzi Benzaghou

Chief Medical Officer

Helen Ho

Chief Business Officer and Chief Strategy Officer

Rohin Mhatre

Chief Technical Operations Officer

Teresa Jurgensen

General Counsel

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.itiger.com/hans/stock/PBLS/company"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"PBLS","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PBLS\",,,,,undefined,":{"symbol":"PBLS","market":"US","secType":"STK","nameCN":"Parabilis Medicines","latestPrice":38.43,"timestamp":1787601600000,"preClose":39.36,"halted":0,"volume":340269,"hourTrading":{"tag":"盘后","latestPrice":38.43,"preClose":38.43,"latestTime":"16:10 EDT","volume":2169,"amount":83354.67,"timestamp":1787602205346,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":-0.023628048780487798,"floatShares":33500000,"shares":124000000,"eps":-23.44581,"marketStatus":"盘后交易","change":-0.93,"latestTime":"08-24 17:49:19 EDT","open":39.42,"high":40.56,"low":38,"amount":13158722,"amplitude":0.065041,"askPrice":39.19,"askSize":51,"bidPrice":38.35,"bidSize":1,"shortable":3,"etf":0,"ttmEps":-23.44581,"tradingStatus":3,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1787616000000},"marketStatusCode":4,"adr":0,"listingDate":1781064000000,"exchange":"NASDAQ","adjPreClose":39.36,"preHourTrading":{"tag":"盘前","latestPrice":39.25,"preClose":39.36,"latestTime":"09:21 EDT","volume":47,"amount":1840.66006,"timestamp":1787577681390,"change":-0.11,"changeRate":-0.002795,"amplitude":0.008892},"postHourTrading":{"tag":"盘后","latestPrice":38.43,"preClose":38.43,"latestTime":"16:10 EDT","volume":2169,"amount":83354.67,"timestamp":1787602205346,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.846395,"impliedVol":0.6007,"impliedVolPercentile":0.2593},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PBLS\",,,,,undefined,":{"symbol":"PBLS","floatShares":33500000,"roa":"--","roe":"--","lyrEps":-60.040199,"volumeRatio":0.846395,"shares":124000000,"dividePrice":0,"high":40.56,"amplitude":0.065041,"preClose":39.36,"low":38,"week52Low":24.51,"pbRate":"4.55","psRate":"32198.11","week52High":41.4899,"institutionHeld":0,"latestPrice":38.43,"committee":-0.961538,"eps":-23.44581,"divideRate":0,"volume":340269,"delay":0,"ttmEps":-23.44581,"open":39.42,"prevYearClose":20,"prevWeekClose":39.36,"prevMonthClose":33.98,"prevQuarterClose":27.37,"fiveDayClose":37.22,"twentyDayClose":31.82,"sixtyDayClose":20},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/PBLS\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-08-13","symbol":"PBLS","fiscalQuarterEnding":"2026/06","expectedEps":-0.16,"name":null,"time":"盘前","type":"earning","dateTimestamp":1786593600000,"reportTimeType":"pre","actualEps":-2.13}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"PBLS\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"PBLS\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.6,"buy":0.4,"hold":0,"sell":0,"strongSell":0,"meanLabel":"STRONG BUY","meanPercent":0.6,"analysts":5,"updateTime":1786939200000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/PBLS\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"PBLS","date":"2026-08-21","current":-1.639099,"percent":0.183673,"low":-31.159897,"twenty":-28.53843,"median":-25.283578,"eighty":-22.890572,"high":-15.535256,"avg":-25.511867,"sd":3.035266,"marketCap":4889445639},"quantilePoints":[{"date":"2026-06-12","current":-23.423744,"twenty":-24.021896,"median":-23.423744,"eighty":-18.690651,"marketCap":3580998591},{"date":"2026-06-18","current":-21.681158,"twenty":-23.280127,"median":-22.147598,"eighty":-21.001488,"marketCap":3314593719},{"date":"2026-06-26","current":-21.956025,"twenty":-22.933884,"median":-22.426629,"eighty":-21.561216,"marketCap":3356615076},{"date":"2026-07-02","current":-23.122126,"twenty":-23.423744,"median":-22.77646,"eighty":-21.681158,"marketCap":3534887500},{"date":"2026-07-10","current":-25.287743,"twenty":-24.420664,"median":-22.938881,"eighty":-21.956025,"marketCap":3865964860},{"date":"2026-07-17","current":-24.204934,"twenty":-24.912925,"median":-23.706058,"eighty":-22.147598,"marketCap":3700426180},{"date":"2026-07-24","current":-27.328421,"twenty":-25.279414,"median":-24.204934,"eighty":-22.705661,"marketCap":4177941603},{"date":"2026-07-31","current":-26.886968,"twenty":-25.665893,"median":-24.321545,"eighty":-22.738979,"marketCap":4110452756},{"date":"2026-08-07","current":-29.635636,"twenty":-26.527142,"median":-24.625564,"eighty":-22.753971,"marketCap":4530666328},{"date":"2026-08-14","current":-29.710599,"twenty":-28.289622,"median":-24.912925,"eighty":-22.788954,"marketCap":4542126698},{"date":"2026-08-21","current":-28.671719,"twenty":-28.53843,"median":-25.283578,"eighty":-22.890572,"marketCap":4889445639}],"updateTime":1787608159629},"@#url:\"stock.company.info\",,undefined,":{"stockCompanyProfile":{"companyId":316822253,"yearFounded":2015,"employeeNum":145,"address":"30 Acorn Park Drive,Cambridge,Massachusetts,United States","zipCode":"02140","officePhone":"(617) 945-9510","fiscalYearEnd":"12-31"},"stockCompanyDetail":{"websiteUrl":"http://www.parabilismed.com","stockEarnings":[{"period":"1week","weight":0.0618},{"period":"1month","weight":0.2775},{"period":"3month","weight":0.968},{"period":"ytd","weight":0.968}],"compareEarnings":[{"period":"1week","weight":-0.0137},{"period":"1month","weight":0.0245},{"period":"3month","weight":0.0269},{"period":"6month","weight":0.1107},{"period":"1year","weight":0.2048},{"period":"ytd","weight":0.1229}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Parabilis Medicines, Inc.于2015年7月10日在特拉华州注册成立。该公司是一家临床阶段的生物制药公司，旨在开发变革性药物，解决历史上驱动人类疾病的不可药物蛋白靶点。其专有平台开创了Helicons，稳定的螺旋肽被设计用于细胞渗透，能够以高特异性结合扁平的细胞内蛋白质目标表面。","exchange":"NASDAQ","name":"Parabilis Medicines","nameEN":"Parabilis Medicines"}},"@#url:\"https://hq.skytigris.cn/fundamental/company/manager/list\",params:#symbol:\"PBLS\",market:\"US\",,,undefined,":{"directors":[{"name":"Mathai Mammen","position":"Chairman and Chief Executive Officer and Director and President"},{"name":"Alan M. Sebulsky","position":"Director"},{"name":"Alexis Borisy","position":"Director"},{"name":"Barbara Weber","position":"Director"},{"name":"Edward Fitzgerald","position":"Director"},{"name":"Jake Simson","position":"Director"},{"name":"Krishna Yeshwant","position":"Director"},{"name":"Rick Klausner","position":"Director"}],"executives":[{"name":"Mathai Mammen","position":"Chairman and Chief Executive Officer and Director and President"},{"name":"Thomas Kotarakos","position":"Chief Financial Officer"},{"name":"Fawzi Benzaghou","position":"Chief Medical Officer"},{"name":"Helen Ho","position":"Chief Business Officer and Chief Strategy Officer"},{"name":"Rohin Mhatre","position":"Chief Technical Operations Officer"},{"name":"Teresa Jurgensen","position":"General Counsel"}]}}}